National Institute of Mental Health (NIMH): Autism Spectrum Disorder trials
The registry lists 15 Autism Spectrum Disorder studies with National Institute of Mental Health (NIMH) as lead sponsor. 3 are open to participants now and 2 have results posted.
Phase 1 1Phase 2 4No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Role of GABAergic Transmission in Auditory Processing in Autism Spectrum DisorderRecruitingNCT04798274Not applicable
- Developing Brain, Impulsivity and CompulsivityRecruitingNCT04631042
- The Neurodevelopmental and Behavioral Phenotyping Screening ProtocolRecruitingNCT00271622
- A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With AutismTerminatedNCT01887132Phase 2Results posted
- Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum DisordersCompletedNCT00251303Phase 2Results posted
- Near Infrared Spectroscopy in Children With Autism and ADHDTerminatedNCT01730079
- A Study of the Association Between Autism and Immune Changes in the BrainTerminatedNCT01322555
- A Study of Divalproex Sodium in Children With ASD and Epileptiform EEGWithdrawnNCT01170325Phase 2
- Brain Imaging Study of Adults With Autism Spectrum DisordersCompletedNCT01093768Phase 1
- Cognitive Neuroscience of Autism Spectrum DisordersCompletedNCT01031407
- A Magnetic Resonance Spectroscopic Examination of Children and Adolescents Taking Riluzole for Obsessive-Compulsive DisorderTerminatedNCT01019967
- Identification of Characteristics Associated With Symptom Remission in AutismCompletedNCT00938054
- Mercury Chelation to Treat AutismWithdrawnNCT00376194Phase 2
- Clinical and Immunological Investigations of Subtypes of AutismCompletedNCT00298246
- Methylphenidate in Children and Adolescents With Pervasive Developmental DisordersCompletedNCT00025779Not applicable